These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies. Hölscher C Rev Neurosci; 2005; 16(3):181-212. PubMed ID: 16323560 [TBL] [Abstract][Full Text] [Related]
5. [Change of fibroblast calcium levels caused by beta-amyloid peptide in Alzheimer disease]. Palotás A; Kálmán J; Laskay G; Juhász A; Janka Z; Penke B Ideggyogy Sz; 2002 May; 55(5-6):164-7. PubMed ID: 12122875 [TBL] [Abstract][Full Text] [Related]
6. [Neurotoxicity of Alzheimer's beta-amyloid protein and membrane lipids]. Kawahara M; Kuroda Y Tanpakushitsu Kakusan Koso; 1999 Oct; 44(13):1982-7. PubMed ID: 10517107 [No Abstract] [Full Text] [Related]
7. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
9. Linking calcium to Abeta and Alzheimer's disease. Green KN; LaFerla FM Neuron; 2008 Jul; 59(2):190-4. PubMed ID: 18667147 [TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity. Roy S; Rauk A Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129 [TBL] [Abstract][Full Text] [Related]
17. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42). Sultana R; Perluigi M; Butterfield DA J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561 [TBL] [Abstract][Full Text] [Related]
18. Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals. Smith IF; Green KN; LaFerla FM Cell Calcium; 2005; 38(3-4):427-37. PubMed ID: 16125228 [TBL] [Abstract][Full Text] [Related]